"Viva Pharma", UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
0 |
0 |
9,047 |
-9,046 |
-9,046 |
- |
-1.37 |
- |
- |
-93,800 |
128,553 |
448 |
34,292 |
2022 |
---|
0 |
0 |
8,790 |
8,788 |
8,788 |
- |
-1.07 |
- |
- |
-84,991 |
91,340 |
1,052 |
32,711 |
2023 |
---|
4,095 |
4,095 |
738 |
735 |
735 |
1.59 |
-1.39 |
54.43 |
17.95 |
-84,255 |
117,158 |
555 |
32,341 |
Register and
explore Okredo data2023 |
---|
4,095 |
4,095 |
738 |
735 |
735 |
1.59 |
-1.39 |
54.43 |
17.95 |
-84,255 |
117,158 |
555 |
32,341 |
Register and
explore Okredo data2023
Turnover (€)
4,095 €- *
Sales per employee (€)
4,095 €- *
Profit before tax (€)
738 €-92 % *
Net Profit (€)
735 €-92 % *
Profit per employee (€)
735 €-92 % *
Working capital requirement
1.59 - *
Debt-to-equity ratio
-1.39 -29.91 % *
Total profitability (%)
54.43 %- *
Net profitability (%)
17.95 %- *
Equity (€)
-84,255 €1 % *
Amounts Payable And Liabilities (€)
117,158 €28 % *
Non-current Assets (€)
555 €-47 % *
CurrentAssets (€)
32,341 €-1 % *